Literature DB >> 8179751

Beta-blocker toxicity: a clinical diagnosis.

J N Love1.   

Abstract

An overdose of the beta-blocking agent metoprolol is presented in which the patient remained asymptomatic despite blood levels that were more than 25 times that reported to be the upper limit of therapeutic. This case emphasizes the need to diagnose beta-blocker toxicity on clinical grounds, not on blood levels that correlate poorly with the severity of symptoms. Furthermore, the question is raised as to whether patients are at any subsequent risk for morbidity, if they have not demonstrated signs or symptoms within 4 hours of ingestion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179751     DOI: 10.1016/0735-6757(94)90160-0

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.

Authors:  G E Gutierrez; D Lalka; I R Garrett; G Rossini; G R Mundy
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

2.  Transdermal lovastatin enhances fracture repair in rats.

Authors:  Gloria E Gutierrez; James R Edwards; Ian R Garrett; Jeffry S Nyman; Brandon McCluskey; Gianni Rossini; Alda Flores; Daria B Neidre; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

3.  Acute Renal Failure with Overdose of Labetalol: Special Considerations in Management.

Authors:  Praveen Guturu
Journal:  Cureus       Date:  2017-09-06

4.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.